Six Years of Infertility, Two Blocked Tubes and a Fixed Budget for One ART Cycle
A 34-year-old woman and her 37-year-old husband attend a district fertility clinic after six years of unprotected intercourse without conception. Her cycles are regular at 28 days and she reports mid-cycle pain; her BMI is 23, her AMH is 1.8 ng/mL, and a hysterosalpingogram shows bilateral blockage at the ampullary-isthmic junction with a normal uterine cavity. Two semen analyses of the husband show 12 million sperm per mL, 30% progressive motility and 2% normal morphology. The clinic offers three packages: three cycles of intrauterine insemination with ovulation induction, one conventional IVF cycle, or one IVF cycle with intracytoplasmic sperm injection. The couple can afford exactly one fresh cycle plus one frozen embryo transfer, and they want to know which package gives the best chance of a live birth and what the chief risks are. The woman is Rh-negative, the husband Rh-positive, and both are anxious to avoid a twin pregnancy.
1. Is intrauterine insemination a defensible first choice here? Decide between conventional IVF and IVF with ICSI, justifying your decision with the tubal and semen findings.
Read the worked answer
IUI is not defensible. IUI places washed sperm in the uterus and depends on at least one patent tube to pick up the oocyte; with bilateral ampullary-isthmic block, gametes cannot meet, so the probability of conception per cycle is close to zero. Adding ovulation induction only adds multiple-gestation and OHSS risk without benefit. The only rational route is IVF, which bypasses the tube entirely.
IVF versus ICSI. The husband's count of 12 million/mL sits below the WHO 2021 lower reference limit of 16 million/mL, but his progressive motility of 30% is at the reference limit, and morphology of 2% is a strict-criteria finding that on its own predicts poor fertilisation only weakly. A count of 12 million with 30% motility gives roughly 3.6 million motile sperm per mL; even after a conservative 10-20% recovery during processing, several hundred thousand motile sperm remain, far more than the ~50,000-100,000 per oocyte needed for conventional insemination. Current guidance does not recommend routine ICSI for mild male-factor parameters because it bypasses natural sperm selection and adds cost without raising live-birth rates.
Plan: conventional IVF, with ICSI held in reserve if fertilisation falls below about 30% of mature oocytes. This preserves the single affordable fresh cycle.
2. Counsel the couple on the three risks that matter most in their situation and how each will be managed.
Read the worked answer
1. Ovarian hyperstimulation syndrome. Her AMH of 1.8 ng/mL and regular cycles suggest normal, not excessive, ovarian reserve, so OHSS risk is low. Management is anticipatory: antagonist protocol, GnRH-agonist trigger instead of hCG if many follicles develop, and a freeze-all strategy with transfer in a later cycle.
2. Multiple pregnancy. Because she wants to avoid twins, elective single embryo transfer of the best day-5 blastocyst is the correct choice, with the remaining blastocysts cryopreserved; her age and reserve make a singleton blastocyst transfer a realistic option rather than a sacrifice.
3. Rh incompatibility. Being Rh-negative is not a barrier to IVF and does not itself change the protocol, but it changes surveillance: her antibody screen must be documented before treatment, anti-D immunoglobulin is needed after any procedure that could cause fetomaternal haemorrhage (oocyte retrieval, miscarriage, ectopic, amniocentesis) and again at about 28 weeks and within 72 hours of delivery if the infant is Rh-positive. Note also that the clinic must be registered under the Assisted Reproductive Technology (Regulation) Act, 2021, and that gamete handling and record-keeping are legally mandated, not optional.
3. On a second visit the couple ask whether surrogacy could be a back-up if IVF fails. How would you answer, and on what grounds?
Read the worked answer
In India the Surrogacy (Regulation) Act, 2021 permits only altruistic surrogacy, and only for defined medical indications such as absence of a uterus, a surgically removed or non-functional uterus, or a condition making pregnancy life-threatening. Intending couples must be Indian citizens, married for at least five years, with a wife aged 23-50 years and a husband aged 26-55 years, and must have no surviving child (except in specified disability/medical exceptions). The surrogate must be a willing, tested, married or widowed/divorced woman aged 25-35 with at least one living child, and no payment beyond medical expenses and insurance is allowed. Commercial surrogacy is prohibited.
In this case the wife has a normal uterine cavity on HSG and no stated uterine pathology; her problem is tubal, which IVF is designed to solve. She therefore does not meet the medical-indication requirement, and a clinic offering surrogacy here would be acting outside the Act. The honest answer is that surrogacy is neither legally available nor medically indicated for them, and that their effort is better spent on optimising the single fresh cycle and using the frozen blastocyst if needed. Mentioning adoption as a separate legal route is appropriate, but it should not be presented as a substitute for treatment they can still pursue.